$18.26
-0.1-0.54%
Last update: Dec 16, 10:20 AM
Comments
Loading...
Bicara Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:BCAX | Benzinga
Bicara Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 10
EPS
$-0.670
Quarterly Revenue
$0.00
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Bicara Therapeutics using advanced sorting and filters.
Bicara Therapeutics (BCAX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-10 | $-0.67 | $-0.54 | -24.1 % |
| Q2 | 2025-08-12 | $-0.50 | $-0.54 | 7.41 % |
| Q1 | 2025-05-13 | $-0.68 | $-0.38 | -79.0 % |
| Q4 | 2025-03-27 | $-0.39 | $-0.29 | -34.5 % |
Bicara Therapeutics (BCAX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Bicara Therapeutics (NASDAQ:BCAX) reporting earnings?
Bicara Therapeutics (BCAX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 10, 2025 for Q3.
What were the latest earnings per share (EPS) for Bicara Therapeutics (NASDAQ:BCAX)?
Bicara Therapeutics (BCAX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 10, 2025 for Q3 and the Actual EPS was $-0.67, which missed the estimate of $-0.54.
What were Bicara Therapeutics’s (NASDAQ:BCAX) revenues?
Bicara Therapeutics (BCAX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 10, 2025 for Q3 and the Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
